🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
DexTech Medical AB (publ) (XSAT:DEX)
Sweden flag Sweden · Delayed Price · Currency is SEK
10.20
-0.20 (-1.92%)
At close: Sep 30, 2026

DexTech Medical AB Income Statement

Millions SEK. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
---5.398.713.12
Revenue Growth
----38.18%179.60%390.65%
Cost of Revenue
0.2-----
Gross Profit
-0.2--5.398.713.12
Selling, General & Admin
5.976.574.337.2510.595.36
Other Operating Expenses
-4.47-5.01-3.22---
Operating Expenses
6.596.655.3210.9313.658.39
Operating Income
-6.79-6.65-5.32-5.55-4.94-5.27
Interest & Investment Income
0.130.190.470.840.35-
Pretax Income
-6.66-6.46-4.84-4.71-4.59-5.27
Net Income
-6.66-6.46-4.84-4.71-4.59-5.27
Net Income to Common
-6.66-6.46-4.84-4.71-4.59-5.27
Net Income Growth
------
Shares Outstanding (Basic)
181819191817
Shares Outstanding (Diluted)
181819191817
Shares Change
-0.96%-0.96%-1.00%2.51%8.02%14.72%
EPS (Basic)
-0.36-0.35-0.26-0.25-0.25-0.31
EPS (Diluted)
-0.36-0.35-0.26-0.25-0.25-0.31
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
---100.00%100.00%100.00%
Operating Margin
----103.04%-56.70%-169.14%
Profit Margin
----87.38%-52.70%-169.14%
EBITDA
-6.63-6.49-5.17-5.39-4.77-5.03
EBITDA Margin
----100.17%-54.78%-161.32%
D&A For EBITDA
0.160.160.150.150.170.24
EBIT
-6.79-6.65-5.32-5.55-4.94-5.27
EBIT Margin
----103.04%-56.70%-169.14%
Revenue as Reported
---5.398.713.12